Focused on transforming innovation into medicine and developing NYC into one of the premier biotech ecosystems
Executive Director, Site Head, NYC
Brandy Houser, PhD
Dr. Brandy Houser is the Site Head for NYC and has led the expansion of Celdara Medical into the Greater NYC region where she is responsible for sourcing and vetting new pipeline assets and all operations. She has led financing, preclinical development, and strategy across the entire NYC pipeline and continues to be a passionate member of the NYC biotech ecosystem through educational content creation as well as through her work as a co-founder of Fiddlehead Foundation, a not-for-profit organization that builds dynamic life science ecosystems. Dr. Houser continues to provide development and intellectual property strategy and know-how to multiple NYC academic institutions and previously supported the NY Economic Development Corporation as the Investment Director of Accelerate New York (Fund II) in their deployment of seed financing to NYC start-up companies. Previously, Brandy was an Investment Associate at Brandon Capital Partners, an Australian venture capital firm and the Alliance Manager for Partners Healthcare, the corporate entity that oversees operations for the Massachusetts General Hospital and the Brigham and Women’s Hospital. During this time, she managed technologies from both hospitals as well as programs for Pfizer’s Center for Therapeutic Innovation. She also helped to create the business and operations plan for The Human Translational Immunology Center at the Brigham and Women’s Hospital. Brandy received her Ph.D. in immunology from Harvard University under the guidance of Dr. Jack Strominger. During her graduate career she was also a commercialization fellow at Harvard Medical School. Dr. Houser is a co-founder and current board member at Women Accelerators, a not-for-profit organization that is geared towards providing the skills women need to advance their careers at all stages.
Jean-Loup Romet Lemonne, MD
Dr. Jean-Loup Romet-Lemonne joined Celdara Medical in 2017 as Senior Advisor, working directly with the NYC Site Head advising on all areas of strategy and business development the NYC pipeline. Prior to joining Celdara, he was Senior Advisor of Global Development at Institut Pasteur working directly with the Institut Pasteur’s President for the development of strategic initiatives in the US. Dr. Romet-Lemonne has an extensive biotech career spanning more than three decades and include being the Founder and CEO of IDM Pharma Inc. (NASDAQ:IDMI) now part of Takeda oncology. At IDM, Jean-Loup pioneered anti-cancer immunotherapy with the development of a cellular therapy armed with bi-specific antibodies and brought to market a novel biopharma product that changed patient outcomes in pediatric osteosarcoma. Jean-Loup has been a Senior Scientist in the Cancer Biology Department at the Harvard School of Public Health, and Associate Professor at the Medical School of Tours University in France. Dr. Romet-Lemonne received his MD from Tours University, completed business training at HEC in France, and executive training at Stanford University’s Graduate School of Business. Jean-Loup is an entrepreneur guru and continues to mentor scientific founders. He is also an active contributor to the development of the NYC life-science ecosystem as a co-founder of the Fiddlehead Foundation. Jean-Loup enjoys running all over NYC, but most especially in Central Park and along the Hudson River.
Jing Gong, PhD
Jing is an Associate at Celdara Medical NYC. She supports the entire New York pipeline, spanning RNA platforms to antibody therapies to diagnostics. Prior to Celdara, Jing was a project manager at the Translational Research Accelerator, hosted at Columbia University, where she worked with a cross-functional team of MDs, scientific founders, researchers and executives-in-residence to reach IND-enabling milestones. Jing also has worked extensively with Columbia Technology Ventures, aiding Columbia University researchers in the technology development process. Jing received her BS in Chemical Engineering from UCLA and her MS/PhD in Biomedical Engineering from Columbia University. She enjoys rock climbing, backpacking and trying to complete the recipes in her Milk Street subscription.
Partnering with New York Institutions and creating innovative solutions in diversified disease areas